Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Special JACC Issue Devoted to Women’s CV HealthFrom an early age, women face unique and often underrecognized cardiovascular risks. The latest issue of JACC highlights the continued evolution of sex-informed cardiovascular care and raises important questions about age, treatment patterns and cardiovascular risk in women.
- ACC Announces Inaugural Fellow For Thad and Gerry Waites Rural CV Research FellowshipThe ACC will recognize Plicy Perez-Kersey, MD, as the first recipient of the Thad and Gerry Waites Rural Cardiovascular Research Fellowship Award. Perez-Kersey will be honored at ACC.26, taking place March 28-30, in New Orleans.
- Does Excluding High-Risk TAVR Patients Improve Hospital-Level Performance Metrics? | NCDR StudyExcluding TAVR patients with the highest risk did not improve hospital-level, risk-adjusted outcomes, according to a recent study published in Circulation: Cardiovascular Interventions.
- Unpacking CV Nutritional Controversies in 2026 | JACC: Advances State-of-the-Art ReviewIn response to increased controversy over what makes up a healthy diet, a recent JACC: Advances State-of-the-Art Review dives into the evidence both for and against several controversial foods and provides recommendations based on the available literature on cardiovascular health and outcomes.
- No Direct Link Between Statins and Potential Treatment Effects | Meta-AnalysisA meta-analysis of individual patient data on all adverse events in large-scale, long-term trials of statin therapy found increases in hepatic transaminase and other liver function tests related to statin intensity, but found no evidence that statins cause the majority (62 of 66) of other adverse effects listed in statin labeling...